Business Wire

European Medicines Agency approves TWYNSTA ® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions ...

TWYNSTA ® is a new highly effective and well tolerated single pill combination therapy of telmisartan, an angiotensin receptor blocker and amlodipine, a calcium channel blocker, for the treatment of ...
elEconomista

Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals

In the US, TWYNSTA ® is approved by the FDA for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to ...
Monthly Prescribing Reference

Twynsta approved for the treatment of hypertension

TWYNSTA (telmisartan/amlodipine) tablets by Boehringer Ingelheim The FDA has approved Twynsta (telmisartan/amlodipine tablets, from Boehringer Ingelheim) for the ...
Monthly Prescribing Reference

Combination Hypertension Treatment Discontinued

Drug discontinued-text The Food and Drug Administration (FDA) has posted a discontinuation notice for Twynsta (telmisartan, amlodipine; Boehringer Ingelheim) 80mg/10mg tablets. The Food and Drug ...